Pharmaceutical Executive, November 2007: Consultants Confidential
Consultants Confidential
NEW CHALLENGES, such as the best way to measure the performance of products under Medicare Part D, are often best solved through incremental improvement. Consultants who work the same problem in four or five companies simultaneously will have the ability to complete more “cycles” than a particular client organization. My belief is that consultants can take on these issues faster, better, and cheaper than any single pharmaceutical company.
Pharmaceutical companies are huge relative to companies in most other industries, but many of their business issues are fragmented by function and market segment. I don’t think about 10 big companies, but rather about 100 independent brands that are at different stages of their life cycle, with different competitive environments, different access issues. Many times there is a lot more similarity in terms of needs between brand organizations across companies than within a single pharma company.
The Amundsen Group
The Amundsen Group brings a team of seasoned consultants and new approaches that are at the forefront of today’s pharmaceutical sales and marketing environment and can help you navigate the daunting challenges that lie ahead.
News/Events
May 8, 2012
PM360 Article (May 2012) – Copay Coupons: Should They Stay or Should They Go?
January 17, 2012
Pharmaceutical Executive January 2012: Letting the Facts Get in the Way
January 4, 2012
November 9, 2011







